Ketoconazole treatment for Cushing syndrome in McCune-Albright syndrome.
Vong
Cecilia Heng
CH
Forest
Maguelone
M
Nicolino
Marc
M
D018663:Adrenergic Agents / Q000627:therapeutic use; D000324:Adrenocorticotropic Hormone / Q000097:blood; D000616:Aminoglutethimide / Q000627:therapeutic use; D000935:Antifungal Agents / Q000008:administration & dosage* / Q000009:adverse effects; D056486:Chemical and Drug Induced Liver Injury / Q000175:diagnosis / Q000209:etiology / Q000517:prevention & control; D003480:Cushing Syndrome / Q000097:blood / Q000188:drug therapy* / Q000209:etiology* / Q000652:urine; D004791:Enzyme Inhibitors / Q000627:therapeutic use; D005260:Female; D005359:Fibrous Dysplasia, Polyostotic / Q000097:blood / Q000150:complications* / Q000652:urine; D006801:Humans; D006854:Hydrocortisone / Q000097:blood / Q000652:urine; D007223:Infant; D007654:Ketoconazole / Q000008:administration & dosage* / Q000009:adverse effects; D008111:Liver Function Tests; D008797:Metyrapone / Q000627:therapeutic use; D012074:Remission Induction
D018663:Adrenergic Agents; D000935:Antifungal Agents; D004791:Enzyme Inhibitors; D000616:Aminoglutethimide; D000324:Adrenocorticotropic Hormone; D007654:Ketoconazole; D006854:Hydrocortisone; D008797:Metyrapone